Home Page Archives | Page 9 of 12

Fifth Eye Home Page News Page

Fifth Eye Receives FDA Clearance for Hemodynamic Monitoring Device

Fifth Eye, a provider of intuitive real-time clinical analytics, today announced the U.S. Food and…

Arboretum_JDMarch 2, 2021

Home Page News Page Strata Oncology

Strata Oncology Announces the Strata PATH Trial with Pfizer as First Pharma Partner

Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…

Arboretum_JDMarch 2, 2021

Flosonics Medical Home Page News Page

Flosonics Medical Closes US$14M Financing Round and Expands Board of Directors

Flosonics Medical, a Canadian medical device company focused on non-invasive hemodynamic monitoring, announced the close…

Arboretum_JDFebruary 2, 2021

Home Page Koya Medical News Page

Koya Medical Closes $11M Financing to Accelerate Treatment for Lymphedema and Venous Disorders

Koya Medical, a healthcare company focused on treating lymphedema and vein disease, today announced the…

Arboretum_JDJanuary 14, 2021

Home Page JUMPCODE Genomics News Page

JUMPCODE Genomics Secures $21M in Series B Funding

Jumpcode Genomics a genome technology company focused on improving the understanding of human disease –…

Arboretum_JDJanuary 12, 2021

EQRx Home Page News Page

EQRx Scales Disruptive Model of Important New Medicines at Lower Prices with $500M Series B Financing

EQRx, a company committed to developing and delivering important new medicines at lower prices, today…

Arboretum_JDJanuary 11, 2021

Home Page News Page Pear Therapeutics

Pear Therapeutics Completes $80M Series D Financing Led by Softbank Vision Fund 2

Pear Therapeutics, Inc., (“Pear” or the “Company”) today announced that it has successfully closed an…

Arboretum_JDDecember 8, 2020

Francis Medical Home Page News Page

Francis Medical Adds Urology Company Coloplast to Its Roster of Investors

Francis Medical, Inc., an early-stage company pioneering urological cancer treatments, beginning with prostate cancer, announced…

Arboretum_JDSeptember 29, 2020

Home Page NeuMoDx News Page

QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems

QIAGEN today announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular,…

Arboretum_JDSeptember 17, 2020

BioIQ Home Page News Page

Why Walmart Health’s Chief Just Left the ‘Dream Job’ to Lead a Testing Company You’ve Never Heard About

As president of Walmart Health, Sean Slovenski was sitting in one of the most influential…

Arboretum_JDSeptember 9, 2020

Home Page